The share of Sun Pharma ended near about 7% higher on Wednesday and the company beat estimate of analysts in the quarter ended June 2018 with the net profit of INR 982.8 crore on strong US and India sales.

In the same quarter previous year, the company had reported a loss of INR 423 crore while in the same quarter current year, it has registered a significant profit and that’s the reason, the shares of Sun Pharmaceutical Industries got a hike of 6.91% on Wednesday on the BSE.

The net revenue for Q1FY19 increased 16.7% Year-on-Year to INR 7,423.9 crore from INR 6,360.8 crore in the same period last year. The EBITDA margin for this quarter was 21.3%.

At 14 August 2018 3:59 PM, Sun Pharmaceutical Industries was quoting at 601.65 up 38.90 or 6.91% on the BSE. This could be a good stock to invest for a long time.

Need any stock market brokerage services; contact us today!